An intracellular assay for viral envelope glycoprotein (env) messenger was employed to analyze the RNA from virus particles of Rous-associated virus type 2. For this assay RNA was microinjected into cells infected by the env-deficient Bryan strain of Rous sarcoma virus [RSV(-) cells]. Only when the injected RNA could be translated by the recipient cells to produce viral envelope glycoprotein was the env deficiency of the RSV(-) cells complemented, enabling them to release focus-forming virus. RNA in a 21S size fraction from the Rous-associated virus particle promoted the release of numerous focus-forming virus from RSV(-) cells, whereas the major 35S virion RNA species was inactive. The env messenger activity sedimented as a sharp peak with high specific activity. RNase Tlgenerated fragments of virion 35S RNA were unable to promote the release of infectious virus from RSV(-) cells. Consequently, the active molecule was most likely to be env messenger which had been encapsulated by the virus particle from the cytoplasm of infected cells. Approximately 95% of the env messenger within the virion was associated with the virion high-molecular-weight RNA complex. The temperature required to dissociate env messenger from the highmolecular-weight complex was indistinguishable from the temperature required to disrupt the complex itself. Virion high-molecular-weight RNA that was associated with env messenger sedimented slightly more rapidly than the bulk virion RNA; this was the strongest evidence that the 21S messenger had been encapsulated directly from the infected cells. These data are considered along with a related observation [concerning the prolonged expression of env messenger after injection into RSV(-) cells] to raise the possibility that virus-encapsulated env messenger can become expressed within subsequently infected cells.
Retrovirus particles contain two 30-40S RNA molecules, each of which encodes the entire virus genome (1, 4, 17) . These associate together within the virion to form a high-molecularweight complex (10, 23) . In mammalian retroviruses this complex is stabilized by base pairing between the two RNA subunits at their 5' termini (3) . This type of association has not yet been observed in avian leukosis viruses, although it is likely that RNA structure within mammalian and avian viruses is similar (2) .
Cells infected by an avian leukosis virus contain two major virus-specific RNA species. One is similar if not identical to the 35S molecule within the virus particle and is believed to function as messenger for viral core proteins and polymerase (19, 21, 31) . The other molecule sediments at 21S and contains primarily the nucleotide sequences of the envelope glycoprotein (env) gene (14, 33) , which is located in the 3' half of the 35S molecule (16, 32) . The 5' termini of both cellular RNA molecules contain identical nucleotide sequences (18, 33) , suggesting that the 21S molecule is the product of RNA processing.
Both analyzed. The predominant 35S virion RNA species was inactive as env messenger following injection into the cytoplasm of RSV(-) cells, but upon injection into their nuclei virion 35S RNA promoted the release of numerous infectious virus from RSV(-) cells. The 358 virion RNA had apparently been converted within the nuclei to env messenger (28) , suggesting that 21S env messenger is produced by nuclear processing.
In contrast to 35S virion RNA, subgenomic RNA from the virus particle functioned directly as env messenger upon cytoplasmic injection into RSV(-) cells (27) . Evidence will be presented here to suggest that the active molecule was 21S env messenger encapsulated by the virus particle directly from the infected cell. The possible implications of this observation are discussed.
MATERIAL AND METHODS
Cell culture and microinJection. Microinjection techniques have been described elsewhere (9, 26) . From 200 to 400 RSV(-) cells were injected for each determination. Culture fluids were collected from injected cells at various intervals for up to 15 h after injection. The preparation and handling of RSV(-) cells, focus assay, and antibody neutralization determination have been described (27) . All chicken embryo fibroblasts used were shown to express no endogenous viral functions and to be susceptible to subgroups A and B but not subgroup E viruses (C/E cells). The titer of RAV-2 virus was determined by end-point dilution as follows. Chicken embryo fibroblasts were infected by various dilutions of the sample (in the presence of DEAE-dextran) and allowed to grow to confluence before subculture with 5 x 10' RSV(-) cells. Two days after subculture, fluids were collected from the plates and assayed for focus-forming virus, which indicated the presence of helper virus in the original inoculum. Numerous determinations were made at each dilution, and the proportion of helper virus-containing plates at each dilution was used to determine the RAV-2 titer.
RNA handling. RNA was prepared from RAV-2 (or RAV-7) virus particles collected at 2-to 3-h intervals. For comparison, some virus were collected at up to 12-h intervals. Virus were purified by isopycnic centrifugation on 20 to 50% sucrose gradients (in 0.15 M NaCl-10 mM Tris-hydrochloride, pH 7.4) for 12 h at 25,000 rpm in a Beckman SW27 rotor. RNA was extracted from the purified virus by treatment with proteinase K at 2 mg/ml (E.M. Laboratories, Elmsford, N.Y.) and 0.5% sodium dodecyl sulfate for 20 min at room temperature, followed by extraction of the reaction mixture with phenol-chloroform (1:1) as described (27) . Virion RNA was labeled by adding
[3H]uridine (New England Nuclear Corp., Boston, Mass.) to infected cells 3 h before virus collection. Velocity sedimentation of RNA was performed on 15 to 30% sucrose gradients as described (27) (Fig. 1) . The data indicated that the active virion env messenger constituted a uniform species with sedimentation characteristics similar to cellular env messenger.
[The number of FFU released after injections into RSV(-) cells is directly proportional to the env messenger activity of the RNA injected (27) ].
The virion 21S RNA had a high specific activity as env messenger (64 FFU/pg of injected RNA, released within 9 h after injection) in relation to the most active 21S mRNA fractions prepared from RAV-2-infected cells (9. 6 FFU/ pg [27] ). In similar experiments, 21S virion RNA from another leukosis virus, RAV-7, expressed messenger activity for envelope glycoprotein, although at a much lower specific activity than observed with RAV-2. Finally, the infectious virus released after injections of RAV-2 virion RNA possessed the antibody neutralization characteristics of RAV-2 (data not shown); this indicates that the virion RNA had faithfully directed synthesis of the envelope glycoprotein molecule.
Inactivity of RNA fragments. The 21S virion messenger might be either env messenger encapsulated directly from the infected cell or a product of 35S RNA cleavage within the virus particle.The specific messenger activity (and in many cases the total messenger activity) of 21S RNA, however, was consistently greater in RNA prepared from virus harvested at short intervals (2 h). The high activity of this RNA, which would have undergone a minimum of degradation within the virus particle, argued against generation of the active molecule by cleavage within the virion.
Further evidence against generation ofthe env messenger within the virion came from the fact that fragments of virion RNA were inactive as env messenger. 35S RAV-2 virion RNA was purified twice by velocity sedimentation to remove contaminating 21S env messenger. The purified 35S RNA was injected into the cytoplasm of RSV(-) cells to verify that no detectable env messenger activity remained. The RNA was next injected into the nuclei of RSV(-) cells to verify that it retained activity as nuclear precursor to env messenger. The 35S RNA was then fragmented by RNase Ti as described in Materials and Methods. Fragments containing polyadenylic acid, and consequently the env gene, were selected on oligodeoxythymidylic acid-cellulose and fractionated by velocityisedi.. mentation. RNA in size fractions corresponding to 24S, 21S, and 18S (Fig. 2) was separately concentrated to 1.2 mg/ml and injected into 300, 600, and 300 RSV(-) cells, respectively. In no case were any FFU released from these injected celis (Table 1) .
As a positive control, 35S RNA that had escaped hydrolysis by RNase Ti (Fig. 2) (Table 1) .
A similar result has been reported in which mild alkaline hydrolysis of 35S RAV-2 virion RNA was shown to be ineffective in generating env messenger (28) . In addition, total cytoplasmic nucleases from HeLa cells were used to cleave 35S virion RNA without the generation of detectable env messenger (Table 1) .
Although random in vitro fragmentation of 35S RAV-2 virion RNA by either chemical or enzymatic techniques did not generate RNA that could function as env messenger within RSV(-) cells, it is possible that specific cleavage of 35S RNA within the virion could generate env messenger. Even specific fragments, however, would have to function actively without the 5' leader sequence normally found in env messenger (18, 33) , and would appear within the cell without a 5' cap structure.
env messenger in the high-molecularweight virion RNA complex. Undenatured RNA from RAV-2 virus particles was fractionated by velocity sedimentation to display the virion high-molecular-weight 60-70S RNA. A constant proportion of RNA in each size fraction from 15S to 70S was microinjected into RSV(-) cells. The release of infectious virus indicated the env messenger content of each fraction. Approximately 95% of the env messenger activity was associated with 60-70S RNA. A small amount of free 21S messenger was observed, but no activity was associated with 35S RNA (Fig.  3) . The env messenger was stably associated with high-molecular-weight RNA, because ethanol precipitation and refractionation of the 60-70S RNA did not promote the release of 21S env messenger.
Thermal dissociation of env messenger from virion RNA. To characterize the bond stabilizing 21S env messenger within the virion high-molecular-weight complex, its thermal stability was determined. RAV-2 virion 60-70S RNA was collected from a sedimentation gradient, heated to various temperatures (from 50 to 600C in 0.1 M NaCl), and refractionated by RNA from purified RAV-2 virus particles was fractionated by velocity sedimentation. Every second fraction from the resulting gradient was combined with the one just before it, and a given volume of the combined fractions was then concentrated to 4 1tl, denatured, and microinjected into 250 RSV(-) cells. 3H-labeled RNA in the high-molecular-weight region (fractions 6-11) promoted the release of approximately 20-fold more infectious virus than that in the 21S region (fractions [14] [15] [16] [17] . No virus were released upon injection of RNA in the 35S region (fractions [12] [13] or below 18S (fractions [18] [19] . The RNA injected for fraction 8-9 was 4 mg/ml. weight RNA is denatured, its sedimentation value shifts abruptly from 60-708 to 358 (6) , so that the ratio of RNA in these two regions of the sedimentation profile indicated the extent of denaturation of the RNA complex. The extent ofrelease ofenv messenger from high-molecularweight RNA was determined by microinjection. RNA in three regions of the gradient (60-70S, 35S, and 21S; see Fig. 4 These results indicate that the bond holding env messenger within the virion RNA complex was similar if not identical to the bond that stabilized the virion complex itself. This bond might have involved the 5' terminus of the env messenger, which was identical to that of the 35S virion RNA subunits (and in mammalian virus is known to play a central role in stabilization of the virion RNA complex [2, 3] ). Alternately, the 21S env messenger might have been physically entrapped by the high-molecularweight complex and released only as the complex was disrupted. In either case it is apparent that the env messenger and the virion RNA complex were in intimate contact.
Size ofthe env messenger-containing virion RNA complex. The association of 21S env messenger with the virion high-molecularweight RNA complex is likely to alter the sedimentation characteristics of the latter. To test this possibility, undenatured RAV-2 virion RNA was fractionated by velocity sedimentation.
High-molecular-weight RNA in the most rapidly and the most slowly sedimenting regions of the resulting profile were then separately refractionated by a second sedimentation step (Fig. 5) . Finally, the most rapidly and the most slowly sedimenting regions of the second high-molecular-weight RNA profiles were prepared in equal concentrations (approximately 1.5 mg/ml) and each was injected into 400 RSV(-) cells (Fig. 5) . The rapidly sedimenting RNA contained proportionately more env messenger and promoted the release of 192 FFU, whereas the slowly sedimenting RNA promoted the release of only 6 FFU.
The factors that influence sedimentation characteristics of virion high-molecular-weight RNA are not known, but it is likely that more rapidly sedimenting RNA complexes contain more RNA. On this basis the association of env messenger with rapidly sedimenting virion RNA complexes constitutes strong evidence that the active RNA did not arise by cleavage within the virus particle (since cleavage could not increase the RNA content of the virion high-molecularweight complex).
Translation of high-molecular-weight virion RNA. Determination was finally made of the availability for translation of env messenger RNA within the virion high-molecularweight complex. 60-70S RAV-2 virion RNA was microinjected into RSV(-) cells either without or just after denaturation (1000C for 75 s in 0.15 M KCI). At best, denaturation resulted in only a three-to fivefold increase in the number of infectious virus released after injections of the VOL. 29, 1979 on October 27, 2017 by guest http://jvi.asm.org/ (A) Total (3H-labeled) RNA from purified RAV-2 virus particles was fractionated by velocity sedimentation (toward the left). RNA in the high-molecularweight regions indicated by brackets was then refractionated. The most slowly (B) and most rapidly (C) sedimenting RNA in the resulting gradients (indicated by brackets) was then prepared in equal concentrations, denatured, and injected into 400)RSV(-) cells. The rapidly sedimenting RNA consistentlypromoted the release of from 10-to 20-fold more infectious virus than the slowly sedimenting RNA. otherwise identical RNA preparations. Association with the virion complex did not preclude the translation of microinjected RNA. This result might have been due to general dissociation of the RNA complex within the cytoplasm of infected cells, since helper virus constituted approximately 60% of the infectious virus released after injection of either denatured or undenatured 60-70S RNA. Studies by Cheung et al. (7) suggest that only 35S RNA is directly encapsulated into the virus particle. If so, the injected RNA complex was dissociated by the cell into 35S subunits, which were then encapsulated to form RAV-2 viruses. DISCUSSION RNA present in the avian leukosis virus particle expresses activity as viral envelope glycoprotein messenger. This observation is significant because the major 35S virion RNA species is totally inactive as env messenger. The evidence reported here suggests that the active RNA molecule within the virion is 21S env messenger (27) encapsulated by the virus particle directly from the infected cell. First, the virion molecule displayed physical and biological characteristics similar to the cellular species; the virion-associated messenger activity sedimented as a discrete species at 21S and promoted the same time course of infectious virus production after injection into RSV(-) cells as did env messenger from infected cells (unpublished data). Second, in these experiments translation was carried out by intact cells, and the product had to be biologically active to be observed. Only a natural messenger molecule would be expected to function properly in this system. Third, only 35S and 21S RNA species within infected cells contain env-specific sequences (14, 33) . 21S env messenger could therefore appear within the virion either by direct encapsulation of 21S RNA or by cleavage of 35S RNA within the virus particle. Repeated attempts to generate active env messenger by in vitro fragmentation of 35S virion RNA by enzymatic and chemical means, however, have failed. Finally, rapidly sedimenting virion high-molecular-weight RNA was associated with proportionately more env messenger than slowly sedimenting virion RNA as further evidence against generation of the active virion messenger by fragmentation of 35S virion RNA.
The inactivity of fragments of 35S virion RNA after injection into RSV(-) cells is in contrast to the results reported with cell-free translation. Purchio et al. (22) found that 21S, polyadenylic acid-containing fragments of sarcoma virion RNA (generated by RNase T1) were active in a rabbit reticulocyte cell-free translation system and directed the synthesis of the 60K (presumptive src) protein. The fact that these fragments were translated well in the reticulocyte cell-free system, but similar fragments of RAV-2 virion RNA were not translated upon microinjection into living RSV(-) cells, suggests that RNAs that would not normnally function within a living, homologous cell may be translated by a heterologous cell-free system.
It has been shown that RNAs other than viral 30-40S RNA can be encapsulated into retrovirus particles (5, 15) . This work demonstrates that an mRNA molecule that contains viral-specific sequences istselectively encapsulated by the virus particle and becomes associated in a highly specific way with the virion high-molecular-weight RNA complex. The virion high-molecularweight complex is composed of two 35S RNA subunits, viral RNA-dependent DNA polymerase (30) and the primer (6, 20, 24) for DNA synthesis (which is located near the 5' terminus of the 35S subunit [11, 29] ). Viral DNA synthesis initiates near the 5' terminus of virion RNA, proceeds to the 5' terminus, and then continues, beginning at the 3' terminus of the 35S RNA subunit (8, 13, 25) . Ninety-five percent of the env messenger in RAV-2 virus particles is associated with this complex by a bond whose thermal stability is indistinguishable from that which stabilized the virion complex itself.
It is not known how the messenger-containing virion RNA complex might be arranged; whether the 21S molecule is trapped within the complex or displaces one of the subunits in some intermolecular bonds. Whatever the case, it is apparent that the 21S molecule is intimately associated with the virion RNA. Since env messenger from the cell contains both the 5' and 3' termini of virion 35S RNA, if it were encapsulated into the virus particle in close association with the high-molecular-weight complex, it might become involved in initiation and/or continuation of viral DNA synthesis, leading to the production of a subgenomic provirus. The resulting DNA might contain only nucleotide sequences of the env message; but since this would include the 5' and 3' termini of 35S virion RNA, it would presumably possess the information necessary for integration into host chromosomes and subsequent transcription into env messenger in the absence of other viral sequences.
Evidence that env messenger is encapsulated into the virus particle and becomes closely associated with the virion RNA complex might be helpful in understanding the long-term expression of env messenger after injection into RSV(-) cells. When 21S env messenger from RAV-2-infected cells was injected into RSV(-) cells, a peak in the rate of release oftransforming virus was observed at 9 h, followed by a sharp decline, as expected for a phenomenon dependent upon a messenger with a relatively short half-life. 
